Streetbeat News

Regulatory

SPY

The Philadelphia Federal Reserve's employment index for July came in at -1, compared to estimates of -4.5 and a prior figure of -0.4. This indicates a slight contraction in employment.

Portfolio Pulse from Happy Mohamed

July 20, 2023 | 12:31 pm

SPY

The Philadelphia Fed Manufacturing Index for July came in at -13.5, worse than the estimated -10 and the prior figure of -13.7.

Portfolio Pulse from Happy Mohamed

July 20, 2023 | 12:30 pm

EADSY

Airbus Helicopters, a unit of Airbus SE (OTC:EADSY), has received certification from the Civil Aviation Administration of China (CAAC) for the H175 helicopter, allowing it to begin deliveries in China. Four H175 helicopters will be delivered to Chinese customers in 2023. Airbus Helicopters is committed to working with the Chinese industry to develop the civil market. The company's shares were down by 0.03% to $37.63 on Wednesday.

Portfolio Pulse from Nabaparna Bhattacharya

July 20, 2023 | 12:20 pm

MO

Juul Labs Inc is seeking FDA approval for its next-generation vaporizer, which is already available in the U.K. and Canada. The new device has age-verification features and prevents the use of unauthorized refill cartridges. Earlier this year, Altria Group Inc (NYSE:MO) divested Juul Labs, recording a loss of at least $12.5 billion. Juul Labs is also researching additional flavors like menthol and taking steps to prevent underage access.

Portfolio Pulse from Vandana Singh

July 20, 2023 | 12:16 pm

HRMY

Harmony Biosciences has announced plans to initiate a Phase 3 registrational study of Pitolisant in Prader-Willi Syndrome following an end-of-Phase 2 meeting with the U.S. Food and Drug Administration.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:08 pm

CASI

CASI Pharmaceuticals has acquired all rights and global intellectual property rights related to CB-5339 from Cleave Therapeutics. CASI will also assume responsibility for the US CB-5339 Investigational New Drug Application.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:07 pm

ATXS

The FDA has granted Fast Track Designation to Astria Therapeutics' STAR-0215 for Hereditary Angioedema. STAR-0215 is currently being evaluated in the ALPHA-STAR clinical trial, with initial proof-of-concept results expected in mid-2024.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:03 pm

AWH

Aspira Women's Health has notified Cantor Fitzgerald about suspending its prospectus supplement, dated February 10, on an equity offering deal. The company will not make any sales of common stock under the sales agreement until a new prospectus supplement is filed with the SEC.

Portfolio Pulse from Charles Gross

July 20, 2023 | 11:41 am

THTX

Theratechnologies has announced a 1-for-4 reverse stock split, which will be effective from July 31, 2023, subject to regulatory approvals from the Toronto Stock Exchange and the Nasdaq Stock Market.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 11:03 am

F

GM

TSLA

Tesla Inc has issued a recall for over 17,000 vehicles due to issues with the forward-facing front camera and front-row seat belts. The camera issue affects 1,337 Model S, X, and Y vehicles made in 2023, while the seat belt issue affects 15,869 Model S and X vehicles from 2021 to 2023. Tesla will inspect and correct or replace the parts at no cost to the customers. Tesla's total recalls to date are over 5 million, less than General Motors Co and Ford Motor Co, each of which has recalled over 200 million vehicles.

Portfolio Pulse from Anan Ashraf

July 20, 2023 | 10:17 am